Thiabendazole

GPTKB entity

Statements (50)
Predicate Object
gptkbp:instanceOf gptkb:chemical_compound
herbicide
anthelmintic
gptkbp:ATCCode P02CC01
gptkbp:Bioavailability 100% (oral)
gptkbp:CASNumber 148-79-8
gptkbp:category Fungicide
World Health Organization essential medicine
Anthelmintic
Antifungal agent
Benzimidazole
Human drug
Pesticide
Thiazole
Veterinary drug
gptkbp:chemicalFormula C10H7N3S
gptkbp:Developed_by gptkb:Merck_&_Co.
gptkbp:Discovered_in 1961
gptkbp:Elimination_half-life 1.2 hours
gptkbp:Excretion urine
https://www.w3.org/2000/01/rdf-schema#label Thiabendazole
gptkbp:IUPACName 2-(1,3-thiazol-4-yl)-1H-benzimidazole
gptkbp:Legal_status_(US) prescription only
gptkbp:Mechanism_of_action inhibits fumarate reductase
gptkbp:meltingPoint 304–305 °C
gptkbp:Metabolism hepatic
gptkbp:molecularWeight 201.25 g/mol
gptkbp:Pregnancy_category_(US) C
gptkbp:PubChem_CID gptkb:CHEMBL1431
5430
DB00730
gptkbp:Related_compound gptkb:fenbendazole
gptkb:albendazole
gptkb:mebendazole
oxfendazole
gptkbp:Routes_of_administration oral
topical
gptkbp:Side_effect nausea
vomiting
dizziness
allergic reactions
gptkbp:Solubility_in_water 50 mg/L at 25 °C
gptkbp:UNII 0323TZZ3EC
gptkbp:Used_as postharvest fungicide
gptkbp:Used_to_treat trichinosis
strongyloidiasis
cutaneous larva migrans
gptkbp:bfsParent gptkb:TBZ
gptkb:E233
gptkbp:bfsLayer 7